mRNA |
Epothilone B |
FIMM |
pan-cancer |
AAC |
0.3 |
0.07 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.07 |
mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
SB52334 |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.07 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.07 |
mRNA |
CGP-60474 |
GDSC1000 |
pan-cancer |
AAC |
0.096 |
0.07 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.07 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.07 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.07 |